Net worth: H$1,000
Guest:Cash: hd$1,000   Predictions: hd$0
You currently have hd$1,000 (Hubdub dollars), Hubdub's virtual currency, to stake on your predictions. Your predictions are currently worth hd$0
Home
Leaderboards
Forums
PoliticsSportEntertainmentWorldBusinessTechnologyScienceGeneral

Will the World Health Organization recognize a cure for HIV/AIDS before November 13, 2018?

Background: Note: This is a long-term market.

On November 13, 2008, German hematologist Gero Huetter claimed to have cured an HIV-infection in a patient. The patient was a 42-year old American citizen with advanced leukemia in addition to HIV. Huetter injected the patient with bone marrow from a donor who was naturally resistant to HIV. After 20 months, Huetter says that the patient has not exhibited signs of HIV.

Bone marrow transplants kill about one-third of all patients who receive them. For this reason, "they can't be justified ethically." Also, Huetter's claims have not been verified. Before antivirals were introduced in the 1990's, bone marrow transplants were tried as a desparate method to halt the AIDS epidemic.

This market will settle as 'yes,' if the WHO, or its successor, recognizes any 'cure' for AIDS or HIV before November 13, 2018. 'Treatment' will not count for this market.

Additional information:
http://www.time.com/time/health/article/0,8599,1858843,00.html

Settlement details:As reported by a major mainstream news source.

 
Forecast history %
Yes
43%
No
57%
Question suspends in 8 years

Suspend date: Mon 12th Nov 2018 9pm PST (8 years to go) details

 

Predictions (8)

29 weeks ago
paddy112 predicted No (H$986 at 58%)
44 weeks ago
biloxibeachboy predicted No (H$100 at 58%)
45 weeks ago
frogchop predicted No (H$20 at 57%)
50 weeks ago
freeze predicted Yes (H$20 at 43%)
1 year ago
jhouseholder predicted Yes (H$20 at 43%)

Comments (1)

  1 randburg
Note: This is a long-term market.

SOMEONE has a sense of humour...
posted 1 year ago

Please log in or join to add a comment

Stake virtual dollars on the outcomes of real news stories! Win more if you're right and climb the leaderboards Learn more...

Name
Email
New password
By joining you are agreeing to our terms of service

Related News
This news is selected automatically based on the question, its background, options and tags


score: 10

score: 10
Cellerant Therapeutics Announces Dosing of First Patient in a Phase 1 Trial of CLT-008 for...

biologic designed to rapidly produce mature neutrophils and platelets in vivo and facilitate long-term engraftment in patients undergoing bone marrow or cord blood transplantation, or being treated for chemotherapy- or radiation-induced neutropenia among

score: 10
Cellerant Therapeutics Announces Dosing of First Patient in a Phase 1 Trial of CLT-008 for Hematological Malignancies

biologic designed to rapidly produce mature neutrophils and platelets in vivo and facilitate long-term engraftment in patients undergoing bone marrow or cord blood transplantation, or being treated for chemotherapy- or radiation-induced neutropenia among

score: 10
Advances in Treatments for Patients with Myelodysplastic Syndromes Take Center Stage at 10th Annual International Symposium in P

to patients enrolled in clinical trials, based on findings from David Grinblatt, MD, of the North Shore University Health System, Evanston, IL. In community-based settings, he showed patients with MDS achieved transfusion independence within the first

score: 10
Advances in Treatments for Patients with Myelodysplastic Syndromes Take Center Stage at 10th...

to patients enrolled in clinical trials, based on findings from David Grinblatt, MD, of the North Shore University Health System, Evanston, IL. In community-based settings, he showed patients with MDS achieved transfusion independence within the first